SCHEMBL14907863

SCHEMBL14907863

Nc1ccc(F)c(CNC(=S)NCc2ccnc3[nH]ccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 3/20 0.37
ROCK2 O75116 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
AKT2 P31751 3/20 0.35
CIT O14578 1/20 0.34
KLKB1 P03952 1/20 0.34
PRKCI P41743 3/20 0.34
AXL P30530 1/20 0.34
MET P08581 2/20 0.34
ADRA2B P18089 1/20 0.34
AURKA O14965 1/20 0.34
DAPK3 O43293 1/20 0.34
JAK2 O60674 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
PAK4 O96013 1/20 0.34
NTRK1 P04629 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907885 0.86 PRKCI (0.43) NUDT1MEN1KMT2AAKT2CIT
SCHEMBL14907791 0.84 BRD4 (0.41) MEN1KMT2ACITNTRK1CSF1R
SCHEMBL14907647 0.82 ALDH1A1 (0.42) NUDT1MEN1KMT2AAKT2PRKCI
SCHEMBL14894266 0.81 JAK3 (0.43) CITMETRETFGFR1LTK
SCHEMBL14907663 0.81 AKT1 (0.44) NUDT1CITPRKCIAXLAURKA
SCHEMBL14907813 0.80 NUDT1 (0.40) NUDT1MEN1KMT2AAKT2KLKB1
SCHEMBL14894258 0.79 JAK2 (0.40) NUDT1MEN1KMT2AAKT2KLKB1
SCHEMBL14907651 0.79 AKT1 (0.38) NUDT1KLKB1PRKCIAXLDAPK3
SCHEMBL14907989 0.78 AKT1 (0.38) NUDT1KLKB1PRKCIAXLDAPK3
SCHEMBL14894066 0.78 KLKB1 (0.39) ROCK2MEN1KMT2AAKT2CIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
WO-2013062945-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296204-A1 CHEMICAL COMPOUNDS DNMT1, DNMT3A, DNMT3B NUDT1 829/4885ROCK2 487/4885MEN1 2219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.